» Articles » PMID: 33718106

Predicting Metastasis Risk in Pancreatic Neuroendocrine Tumors Using Deep Learning Image Analysis

Overview
Journal Front Oncol
Specialty Oncology
Date 2021 Mar 15
PMID 33718106
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The prognosis of patients with pancreatic neuroendocrine tumors (PanNET), the second most common type of pancreatic cancer, varies significantly, and up to 15% of patients develop metastasis. Although certain morphological characteristics of PanNETs have been associated with patient outcome, there are no available morphology-based prognostic markers. Given that current clinical histopathology markers are unable to identify high-risk PanNET patients, the development of accurate prognostic biomarkers is needed. Here, we describe a novel machine learning, multiclassification pipeline to predict the risk of metastasis using morphological information from whole tissue slides.

Methods: Digital images from surgically resected tissues from 89 PanNET patients were used. Pathologist-annotated regions were extracted to train a convolutional neural network (CNN) to identify tiles consisting of PanNET, stroma, normal pancreas parenchyma, and fat. Computationally annotated cancer or stroma tiles and patient metastasis status were used to train CNN to calculate a region based metastatic risk score. Aggregation of the metastatic probability scores across the slide was performed to predict the risk of metastasis.

Results: The ability of CNN to discriminate different tissues was high (per-tile accuracy >95%; whole slide cancer regions Jaccard index = 79%). Cancer and stromal tiles with high evaluated probability provided F1 scores of 0.82 and 0.69, respectively, when we compared tissues from patients who developed metastasis and those who did not. The final model identified low-risk (n = 76) and high-risk (n = 13) patients, as well as predicted metastasis-free survival (hazard ratio: 4.71) after adjusting for common clinicopathological variables, especially in grade I/II patients.

Conclusion: Using slides from surgically resected PanNETs, our novel, multiclassification, deep learning pipeline was able to predict the risk of metastasis in PanNET patients. Our results suggest the presence of prognostic morphological patterns in PanNET tissues, and that these patterns may help guide clinical decision making.

Citing Articles

Deep Learning Enabled Scoring of Pancreatic Neuroendocrine Tumors Based on Cancer Infiltration Patterns.

Koc S, Eren O, Esmer R, Kasapoglu F, Saka B, Taskin O Endocr Pathol. 2025; 36(1):2.

PMID: 39847242 PMC: 11757657. DOI: 10.1007/s12022-025-09846-3.


Pancreatic Ductal Adenocarcinoma (PDAC): A Review of Recent Advancements Enabled by Artificial Intelligence.

Mukund A, Afridi M, Karolak A, Park M, Permuth J, Rasool G Cancers (Basel). 2024; 16(12).

PMID: 38927945 PMC: 11201559. DOI: 10.3390/cancers16122240.


A radiomics-based interpretable model to predict the pathological grade of pancreatic neuroendocrine tumors.

Ye J, Fang P, Peng Z, Huang X, Xie J, Yin X Eur Radiol. 2023; 34(3):1994-2005.

PMID: 37658884 PMC: 10873440. DOI: 10.1007/s00330-023-10186-1.


Recent Advancements in Deep Learning Using Whole Slide Imaging for Cancer Prognosis.

Lee M Bioengineering (Basel). 2023; 10(8).

PMID: 37627783 PMC: 10451210. DOI: 10.3390/bioengineering10080897.


ChampKit: A framework for rapid evaluation of deep neural networks for patch-based histopathology classification.

Kaczmarzyk J, Gupta R, Kurc T, Abousamra S, Saltz J, Koo P Comput Methods Programs Biomed. 2023; 239:107631.

PMID: 37271050 PMC: 11093625. DOI: 10.1016/j.cmpb.2023.107631.


References
1.
Salaria S, Shi C . Pancreatic Neuroendocrine Tumors. Surg Pathol Clin. 2016; 9(4):595-617. DOI: 10.1016/j.path.2016.05.006. View

2.
Yao J, Hassan M, Phan A, Dagohoy C, Leary C, Mares J . One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008; 26(18):3063-72. DOI: 10.1200/JCO.2007.15.4377. View

3.
AbdulJabbar K, Raza S, Rosenthal R, Jamal-Hanjani M, Veeriah S, Akarca A . Geospatial immune variability illuminates differential evolution of lung adenocarcinoma. Nat Med. 2020; 26(7):1054-1062. PMC: 7610840. DOI: 10.1038/s41591-020-0900-x. View

4.
Tang L, Gonen M, Hedvat C, Modlin I, Klimstra D . Objective quantification of the Ki67 proliferative index in neuroendocrine tumors of the gastroenteropancreatic system: a comparison of digital image analysis with manual methods. Am J Surg Pathol. 2012; 36(12):1761-70. DOI: 10.1097/PAS.0b013e318263207c. View

5.
Doyle S, Feldman M, Shih N, Tomaszewski J, Madabhushi A . Cascaded discrimination of normal, abnormal, and confounder classes in histopathology: Gleason grading of prostate cancer. BMC Bioinformatics. 2012; 13:282. PMC: 3563463. DOI: 10.1186/1471-2105-13-282. View